Best Alternative to Heyvlema for Memory Decline
Your search for Heyvlema has probably hit a dead end. No supplement, device, or company by that name appears in FDA, FTC, or clinical trial records. The spelling is one letter away from Hey Velma, our daily cognitive support program.
So this guide does two things. It explains what Velma is and is not. Then it ranks the real, evidence-backed options for a parent whose memory is slipping.
Quick answer: Velma is our recommendation. It is a $199 a month cognitive health program. It pairs AI assistants with a dedicated human care manager for daily cognitive sessions, routine support, and family alerts. The first session is free.
Velma is not a supplement, not a prescription drug, and not a licensed therapy clinic. It sits alongside a physician's care plan and does not replace a diagnosis or medical treatment.
Key takeaways:
Velma pricing: Velma costs $199 a month, less than a single in-person therapy session. The first session is free.
Heyvlema is not a product we can verify: No regulator, trial registry, or ranking page lists it. The name matches Hey Velma, which is a daily program delivered by phone, not a pill.
Strongest non-drug evidence: Cognitive stimulation therapy improved cognition and quality of life in a Cochrane review of mild to moderate dementia. The gains were comparable to cholinesterase inhibitor medications.
Supplement caution: The FTC and New York Attorney General charged Prevagen's marketers with deceptive memory claims in 2017. A large trial of ginkgo biloba found no reduction in dementia incidence.
Rule out mimics first: Thyroid disease, B12 deficiency, depression, sleep apnea, and medication side effects can look like Alzheimer's and are treatable. A physician workup comes before any product.
What is Heyvlema, and is there any clinical evidence behind it?
Heyvlema is not a registered supplement, device, or company that we can find in FDA, FTC, or clinical trial records. The closest match is Hey Velma, our daily cognitive support program for older adults with memory loss. If you expected a pill, there is no evidence to review, because the product does not appear to exist under that spelling.
We should be transparent here. We are Hey Velma, and we run the program described in this article, so we have a stake in the subject. The evidence claims below come from the public sources linked in each section, and we say plainly where our own program does not fit.
Velma works by phone. An AI assistant leads short daily cognitive sessions built on evidence-based exercises. A dedicated care manager works alongside the AI assistant, and families receive regular updates and alerts to stay informed of changes.
The results we can share are individual, not trial data. Dara, an independent retiree with Alzheimer's, doubled her attention and working memory in a few weeks. She started going to the gym and reported far less anxiety. Roy, a musician with early Alzheimer's, became happier and more outgoing, which eased the strain on his wife.
If you landed here looking for a supplement that reverses memory loss, no such product exists in the peer-reviewed literature. The rest of this guide ranks what does have evidence, in order of the job each option does best.
What are the top 5 best alternatives to Heyvlema for memory decline?
The top five are Velma, licensed cognitive rehabilitation therapy, group cognitive stimulation therapy, adult day programs, and BrainHQ. Velma covers daily at-home sessions with family alerts, and rehabilitation therapy fits when a physician orders it. Group CST suits social learners, adult day programs give supervised daytime hours, and BrainHQ offers self-directed training. We ranked each by the job it does best, not by a vague quality score.
Velma: best when you need daily structure at home with no insurance paperwork. Velma costs $199 a month and includes daily cognitive sessions, routine support, a dedicated care manager, and family alerts. Sessions work around your parent's schedule. The honest limit: Velma is not licensed therapy, does not supervise anyone in person, and does not diagnose.
Licensed cognitive rehabilitation therapy: best when a physician has ordered a formal plan of care. A speech-language pathologist, occupational therapist, or neuropsychologist delivers goal-based treatment. A typical course runs 45 to 60 minute sessions, one to three times a week, for eight to twelve weeks. Medicare Part B pays when a doctor certifies medical necessity.
The limit: you need a referral, waitlists are common, and the course ends when the plan of care ends. Our plain-English guide to cognitive rehabilitation therapy explains how to get a referral.
Group cognitive stimulation therapy (CST): best when your parent enjoys groups and can travel to them. The standard program runs seven weeks of twice-weekly themed sessions led by a trained facilitator. It carries the strongest randomized evidence of any non-drug option for mild to moderate dementia. Groups run through memory clinics, some Alzheimer's Association chapters, and senior centers, with pricing that varies by provider.
The limit: availability is patchy outside cities, and gains fade once sessions stop.
Adult day programs: best when you need supervised daytime hours plus activities. The most recent national survey put adult day health care at $100 a day, about $2,167 a month for full-time attendance. That buys group activities, meals, and sometimes nursing oversight. The limit: your parent must travel, activities are run for the group rather than one person, and centers close evenings and weekends.
See our 2026 adult day care cost guide for the monthly math.
BrainHQ: best when a tech-comfortable adult wants self-directed brain training. Posit Science sells BrainHQ as a subscription with monthly and annual plans. Confirm current pricing on the BrainHQ website before you buy. Its speed-of-processing exercises were used in the long-running ACTIVE trial, which gives it more evidence than most apps. The limit: no human checks in, and the evidence is strongest in cognitively healthy older adults rather than diagnosed dementia.
A parent who forgets to log in gets nothing.
Option | Best for | Pricing or format | Standout limit |
|---|---|---|---|
Velma | Daily at-home sessions with family alerts | $199 a month, first session free | Not licensed therapy, no in-person supervision |
Cognitive rehabilitation therapy | Physician-ordered, goal-based treatment | Medicare Part B with medical necessity; 8 to 12 week course | Needs a referral, ends when the plan of care ends |
Group CST | Social, facilitated sessions | 7-week program; pricing varies by provider | Patchy availability, gains fade after sessions stop |
Adult day programs | Supervised daytime hours | $100 a day national median | Travel required, closed evenings and weekends |
BrainHQ | Self-directed app training | Monthly or annual subscription; confirm on vendor site | No human follow-up, needs daily motivation |
Is there anything better than Prevagen for memory?
Yes. Any option with randomized trial evidence beats Prevagen. The FTC and New York Attorney General charged its marketers in 2017 for deceptive memory claims. Structured cognitive stimulation, regular aerobic exercise, hearing correction, and blood pressure control all have stronger support than apoaequorin, the jellyfish protein sold in Prevagen capsules.
In January 2017 the FTC and New York's Attorney General charged Prevagen's marketers with deceptive advertising. The complaint stated that the company's own clinical study failed to show a statistically significant improvement on its primary cognitive measures.
The other popular supplements do not fare much better. The Ginkgo Evaluation of Memory study followed more than 3,000 adults aged 75 and older for about six years. It found no reduction in dementia or Alzheimer's incidence.
Omega-3 fatty acids have not slowed decline in trials of people with established Alzheimer's. B vitamins lower homocysteine but improve cognition only when someone is actually deficient. Coconut oil and caprylic acid have no randomized trial showing benefit.
A simple decision rule applies when a label says clinically proven. If you cannot find the trial on clinicaltrials.gov or in PubMed, treat the claim as marketing. Spend the money on something with a published effect.
Which non-drug approaches have the strongest evidence for slowing memory decline?
Cognitive stimulation therapy, regular aerobic exercise, treating hearing loss, and controlling blood pressure have the strongest evidence. The Lancet Commission estimates that addressing 12 modifiable risk factors could prevent or delay about 40 percent of dementia cases. Music therapy and mindfulness help mood more than memory, and supplements sit at the bottom of the evidence ladder.
Strong tier: a 2012 Cochrane review of cognitive stimulation therapy trials found significant gains in cognition and quality of life for mild to moderate dementia. The 2020 Lancet Commission listed hearing loss, hypertension, physical inactivity, and social isolation among its 12 modifiable factors.
Moderate tier: Mediterranean and MIND-style eating patterns are linked to lower risk in observational studies. Still, the 2023 MIND diet trial did not beat its control diet. Computerized training showed lasting benefits in the ACTIVE trial. Music therapy reduces agitation and lifts mood, and mindfulness helps stress and sleep.
Weak tier: ginkgo biloba, omega-3 supplements, B vitamins without a deficiency, and coconut oil. Unproven tier: transcranial electromagnetic devices, stem cell clinics, and any protocol that promises reversal.
We wrote a longer breakdown of whether cognitive stimulation therapy actually works, including why the gains fade without maintenance. That durability problem is the reason we built Velma around daily sessions rather than a short course.
Should you consider prescription drugs for memory loss instead?
Ask about them, because prescriptions and programs are not either-or. Cholinesterase inhibitors such as donepezil treat symptoms in Alzheimer's, and memantine adds help in moderate to severe stages. The anti-amyloid infusions lecanemab and donanemab slow early Alzheimer's modestly. A prescription is warranted when a physician confirms the diagnosis and stage; no over-the-counter supplement matches any of them.
The FDA granted lecanemab traditional approval in July 2023, and donanemab followed in 2024. Both require confirmed amyloid on a PET scan or spinal fluid test, regular infusions, and MRI monitoring for brain swelling or bleeding known as ARIA.
In its 18-month pivotal trial, lecanemab slowed decline on the main clinical scale by 27 percent compared with placebo. That is a slower slide, not a recovery, and eligibility is limited to mild cognitive impairment or mild dementia due to Alzheimer's.
Cholinesterase inhibitors are cheaper and widely prescribed, with side effects that include nausea and a slowed heart rate. The decision rule: if your parent has not had a formal diagnosis, none of these drugs are on the table yet. That is one more reason the doctor visit comes first.
Can memory loss actually be reversed?
Sometimes, but only when the cause is reversible. Memory loss from hypothyroidism, B12 deficiency, depression, sleep apnea, or sedating medications often improves with treatment. Alzheimer's disease has not been reversed in any trial, and approved drugs only slow decline. Headline devices like NeuroEM rest on an eight-person pilot without a control group, so be skeptical of any product promising reversal.
The NeuroEM study that generated the headlines was a 2019 open-label pilot. Eight people with mild to moderate Alzheimer's wore a transcranial electromagnetic treatment device for two months and showed improved test scores. There was no placebo group, and the device remains investigational, not FDA-approved.
Blood tests that measure tau proteins are improving early detection, and brain imaging can now confirm amyloid before symptoms are severe. Those are detection tools. They change when treatment starts, not whether the disease reverses.
What does improve within a stage is engagement, mood, attention, and daily function. That is the realistic target for any program, including ours, and it is the outcome families should measure.
What conditions mimic Alzheimer's and could be treatable?
The most common mimics are hypothyroidism, vitamin B12 deficiency, depression, obstructive sleep apnea, and untreated hearing loss. Others include side effects from anticholinergic drugs or sleep aids, urinary tract infections causing delirium, and normal pressure hydrocephalus. Each has a standard test or screen, and each can improve with treatment, which is why a workup precedes any program or supplement.
The National Institute on Aging notes that memory problems do not always mean dementia. Medications, emotional problems, and medical conditions can all cause lapses that look like Alzheimer's.
Bring a complete medication list to the appointment, including over-the-counter sleep aids and allergy pills. Diphenhydramine, found in many PM products, is an anticholinergic that can cloud thinking in older adults.
Ask about snoring and daytime sleepiness, which point to sleep apnea. Ask for a depression screen, because depression in older adults often shows up as forgetfulness rather than sadness. And get a hearing test, since the Lancet Commission ranked hearing loss as the largest single modifiable risk factor.
What is the difference between Alzheimer's disease and dementia?
Dementia is an umbrella term for a decline in memory, reasoning, or language severe enough to interfere with daily life. Alzheimer's disease is one cause of dementia, and the most common one, accounting for an estimated 60 to 80 percent of cases. Vascular dementia, Lewy body dementia, and frontotemporal dementia are other causes with different patterns.
The Alzheimer's Association explains the difference between dementia and Alzheimer's in plain terms: dementia describes the symptoms, Alzheimer's names a specific disease behind them.
There are two stages before dementia worth knowing. Normal aging means occasionally misplacing keys and remembering later. Mild cognitive impairment means measurable decline on testing while daily life still runs, and it does not always progress to dementia.
These labels matter for choosing support. CST evidence applies to mild and moderate dementia. Velma is designed for early memory loss and early Alzheimer's, when a parent can still follow a phone conversation and act on a routine prompt.
When should your parent see a doctor, and what tests are used?
See a doctor as soon as memory lapses repeat, affect safety, or worry the family, rather than waiting for a crisis. Medicare covers a cognitive assessment at the annual wellness visit and a separate care planning visit after a diagnosis. Expect a history, a screening test such as the MoCA or MMSE, blood work, and often brain imaging.
Triggers that justify a visit now include missed medications and getting lost on a familiar route. Repeating the same question within minutes or unpaid bills piling up also count. One episode is a flag; a pattern is a reason to book.
Medicare's cognitive assessment and care plan services page describes what is covered. Blood work usually includes thyroid function, B12, a complete blood count, and a metabolic panel. An MRI or CT scan rules out strokes, tumors, and fluid buildup.
A specialist may add amyloid PET imaging, spinal fluid analysis, or newer blood biomarker tests. Our guide to what insurance covers for cognitive support programs explains which of these steps Medicare pays for and which it does not.
How should you evaluate any memory product or alternative claim?
Run five checks, starting with the trial rather than the testimonial. Confirm the study population matches your parent's stage, and look for FTC or FDA warning letters. Ask a pharmacist about drug interactions, and price it against the alternatives with evidence. A product that passes none of these belongs in the unproven tier regardless of how it is advertised.
Red flags include the phrase clinically proven with no citation, a patented proprietary blend, and the word reverses. Countdown timers and testimonials from people whose diagnosis is never stated are two more. A legitimate product names its study, its sample size, and its limits.
Apply the same test to us. Velma's published results are individual stories, not a randomized trial. Our sessions use evidence-based cognitive exercises, and our pricing is public at $199 a month. The first session is free so you can judge the fit yourself.
On cost, the comparison is simple. Velma costs $199 a month, which is a fraction of what full-time adult day care costs at the national median. We compared the app route separately in Velma vs brain games at home.
How did we compare these options?
We compared published pricing for Velma, Medicare coverage rules for cognitive rehabilitation therapy, and the national cost survey figure for adult day care. We also reviewed provider listings for group CST and BrainHQ's public subscription model. We checked each option's evidence against the Cochrane CST review, the Lancet Commission report, and FDA and FTC records.
How do you get started with Velma?
Start with the free first session, which comes with no commitment and no insurance authorization. You tell us about your parent, and we schedule a short phone session at a time that suits them. A care manager follows up with what we observed. If it fits, the program continues at $199 a month with daily sessions and family alerts.
You can book your parent's free first session at heyvelma.com. Reach our team through heyvelma.com with questions before you decide.
Velma is not a substitute for a physician-directed treatment plan. If your parent has not had a cognitive workup yet, book that appointment first and start Velma alongside it.
What do people also ask?
What is the best medication to help with memory loss?
There is no single best drug. Cholinesterase inhibitors such as donepezil, rivastigmine, and galantamine treat Alzheimer's symptoms, and memantine helps in moderate to severe stages. The anti-amyloid infusions lecanemab and donanemab slow early Alzheimer's modestly in people with confirmed amyloid. All require a physician's diagnosis, and none are available over the counter.
What mimics Alzheimer's?
Hypothyroidism, vitamin B12 deficiency, depression, obstructive sleep apnea, and untreated hearing loss can all look like Alzheimer's. So can side effects from anticholinergic drugs and sleep aids, urinary tract infections causing delirium, and normal pressure hydrocephalus. Each has a standard test, and each can improve with treatment, so ask for a full workup before assuming dementia.
Is there anything better than Prevagen for memory?
Yes, and the FTC and New York Attorney General charged Prevagen's marketers with deceptive memory claims in 2017. The company's own study failed on its primary measures. Cognitive stimulation therapy, aerobic exercise, hearing correction, and blood pressure control all have stronger evidence. Velma delivers daily structured cognitive sessions at home for $199 a month.
What is the main difference between Alzheimer's disease and dementia?
Dementia is the umbrella term for a decline in memory, reasoning, or language that interferes with daily life. Alzheimer's disease is the most common cause of dementia, estimated at 60 to 80 percent of cases. Vascular, Lewy body, and frontotemporal dementia are other causes with different symptom patterns and treatment paths.
Is Heyvlema the same as Hey Velma?
We cannot find any product, supplement, or company called Heyvlema, a spelling one letter off from Hey Velma. Velma is our daily phone-based program, not a pill. It pairs AI assistants with a dedicated care manager for cognitive sessions, routine support, and family alerts. It costs $199 a month, and the first session is free.
Your search for Heyvlema has probably hit a dead end. No supplement, device, or company by that name appears in FDA, FTC, or clinical trial records. The spelling is one letter away from Hey Velma, our daily cognitive support program.
So this guide does two things. It explains what Velma is and is not. Then it ranks the real, evidence-backed options for a parent whose memory is slipping.
Quick answer: Velma is our recommendation. It is a $199 a month cognitive health program. It pairs AI assistants with a dedicated human care manager for daily cognitive sessions, routine support, and family alerts. The first session is free.
Velma is not a supplement, not a prescription drug, and not a licensed therapy clinic. It sits alongside a physician's care plan and does not replace a diagnosis or medical treatment.
Key takeaways:
Velma pricing: Velma costs $199 a month, less than a single in-person therapy session. The first session is free.
Heyvlema is not a product we can verify: No regulator, trial registry, or ranking page lists it. The name matches Hey Velma, which is a daily program delivered by phone, not a pill.
Strongest non-drug evidence: Cognitive stimulation therapy improved cognition and quality of life in a Cochrane review of mild to moderate dementia. The gains were comparable to cholinesterase inhibitor medications.
Supplement caution: The FTC and New York Attorney General charged Prevagen's marketers with deceptive memory claims in 2017. A large trial of ginkgo biloba found no reduction in dementia incidence.
Rule out mimics first: Thyroid disease, B12 deficiency, depression, sleep apnea, and medication side effects can look like Alzheimer's and are treatable. A physician workup comes before any product.
What is Heyvlema, and is there any clinical evidence behind it?
Heyvlema is not a registered supplement, device, or company that we can find in FDA, FTC, or clinical trial records. The closest match is Hey Velma, our daily cognitive support program for older adults with memory loss. If you expected a pill, there is no evidence to review, because the product does not appear to exist under that spelling.
We should be transparent here. We are Hey Velma, and we run the program described in this article, so we have a stake in the subject. The evidence claims below come from the public sources linked in each section, and we say plainly where our own program does not fit.
Velma works by phone. An AI assistant leads short daily cognitive sessions built on evidence-based exercises. A dedicated care manager works alongside the AI assistant, and families receive regular updates and alerts to stay informed of changes.
The results we can share are individual, not trial data. Dara, an independent retiree with Alzheimer's, doubled her attention and working memory in a few weeks. She started going to the gym and reported far less anxiety. Roy, a musician with early Alzheimer's, became happier and more outgoing, which eased the strain on his wife.
If you landed here looking for a supplement that reverses memory loss, no such product exists in the peer-reviewed literature. The rest of this guide ranks what does have evidence, in order of the job each option does best.
What are the top 5 best alternatives to Heyvlema for memory decline?
The top five are Velma, licensed cognitive rehabilitation therapy, group cognitive stimulation therapy, adult day programs, and BrainHQ. Velma covers daily at-home sessions with family alerts, and rehabilitation therapy fits when a physician orders it. Group CST suits social learners, adult day programs give supervised daytime hours, and BrainHQ offers self-directed training. We ranked each by the job it does best, not by a vague quality score.
Velma: best when you need daily structure at home with no insurance paperwork. Velma costs $199 a month and includes daily cognitive sessions, routine support, a dedicated care manager, and family alerts. Sessions work around your parent's schedule. The honest limit: Velma is not licensed therapy, does not supervise anyone in person, and does not diagnose.
Licensed cognitive rehabilitation therapy: best when a physician has ordered a formal plan of care. A speech-language pathologist, occupational therapist, or neuropsychologist delivers goal-based treatment. A typical course runs 45 to 60 minute sessions, one to three times a week, for eight to twelve weeks. Medicare Part B pays when a doctor certifies medical necessity.
The limit: you need a referral, waitlists are common, and the course ends when the plan of care ends. Our plain-English guide to cognitive rehabilitation therapy explains how to get a referral.
Group cognitive stimulation therapy (CST): best when your parent enjoys groups and can travel to them. The standard program runs seven weeks of twice-weekly themed sessions led by a trained facilitator. It carries the strongest randomized evidence of any non-drug option for mild to moderate dementia. Groups run through memory clinics, some Alzheimer's Association chapters, and senior centers, with pricing that varies by provider.
The limit: availability is patchy outside cities, and gains fade once sessions stop.
Adult day programs: best when you need supervised daytime hours plus activities. The most recent national survey put adult day health care at $100 a day, about $2,167 a month for full-time attendance. That buys group activities, meals, and sometimes nursing oversight. The limit: your parent must travel, activities are run for the group rather than one person, and centers close evenings and weekends.
See our 2026 adult day care cost guide for the monthly math.
BrainHQ: best when a tech-comfortable adult wants self-directed brain training. Posit Science sells BrainHQ as a subscription with monthly and annual plans. Confirm current pricing on the BrainHQ website before you buy. Its speed-of-processing exercises were used in the long-running ACTIVE trial, which gives it more evidence than most apps. The limit: no human checks in, and the evidence is strongest in cognitively healthy older adults rather than diagnosed dementia.
A parent who forgets to log in gets nothing.
Option | Best for | Pricing or format | Standout limit |
|---|---|---|---|
Velma | Daily at-home sessions with family alerts | $199 a month, first session free | Not licensed therapy, no in-person supervision |
Cognitive rehabilitation therapy | Physician-ordered, goal-based treatment | Medicare Part B with medical necessity; 8 to 12 week course | Needs a referral, ends when the plan of care ends |
Group CST | Social, facilitated sessions | 7-week program; pricing varies by provider | Patchy availability, gains fade after sessions stop |
Adult day programs | Supervised daytime hours | $100 a day national median | Travel required, closed evenings and weekends |
BrainHQ | Self-directed app training | Monthly or annual subscription; confirm on vendor site | No human follow-up, needs daily motivation |
Is there anything better than Prevagen for memory?
Yes. Any option with randomized trial evidence beats Prevagen. The FTC and New York Attorney General charged its marketers in 2017 for deceptive memory claims. Structured cognitive stimulation, regular aerobic exercise, hearing correction, and blood pressure control all have stronger support than apoaequorin, the jellyfish protein sold in Prevagen capsules.
In January 2017 the FTC and New York's Attorney General charged Prevagen's marketers with deceptive advertising. The complaint stated that the company's own clinical study failed to show a statistically significant improvement on its primary cognitive measures.
The other popular supplements do not fare much better. The Ginkgo Evaluation of Memory study followed more than 3,000 adults aged 75 and older for about six years. It found no reduction in dementia or Alzheimer's incidence.
Omega-3 fatty acids have not slowed decline in trials of people with established Alzheimer's. B vitamins lower homocysteine but improve cognition only when someone is actually deficient. Coconut oil and caprylic acid have no randomized trial showing benefit.
A simple decision rule applies when a label says clinically proven. If you cannot find the trial on clinicaltrials.gov or in PubMed, treat the claim as marketing. Spend the money on something with a published effect.
Which non-drug approaches have the strongest evidence for slowing memory decline?
Cognitive stimulation therapy, regular aerobic exercise, treating hearing loss, and controlling blood pressure have the strongest evidence. The Lancet Commission estimates that addressing 12 modifiable risk factors could prevent or delay about 40 percent of dementia cases. Music therapy and mindfulness help mood more than memory, and supplements sit at the bottom of the evidence ladder.
Strong tier: a 2012 Cochrane review of cognitive stimulation therapy trials found significant gains in cognition and quality of life for mild to moderate dementia. The 2020 Lancet Commission listed hearing loss, hypertension, physical inactivity, and social isolation among its 12 modifiable factors.
Moderate tier: Mediterranean and MIND-style eating patterns are linked to lower risk in observational studies. Still, the 2023 MIND diet trial did not beat its control diet. Computerized training showed lasting benefits in the ACTIVE trial. Music therapy reduces agitation and lifts mood, and mindfulness helps stress and sleep.
Weak tier: ginkgo biloba, omega-3 supplements, B vitamins without a deficiency, and coconut oil. Unproven tier: transcranial electromagnetic devices, stem cell clinics, and any protocol that promises reversal.
We wrote a longer breakdown of whether cognitive stimulation therapy actually works, including why the gains fade without maintenance. That durability problem is the reason we built Velma around daily sessions rather than a short course.
Should you consider prescription drugs for memory loss instead?
Ask about them, because prescriptions and programs are not either-or. Cholinesterase inhibitors such as donepezil treat symptoms in Alzheimer's, and memantine adds help in moderate to severe stages. The anti-amyloid infusions lecanemab and donanemab slow early Alzheimer's modestly. A prescription is warranted when a physician confirms the diagnosis and stage; no over-the-counter supplement matches any of them.
The FDA granted lecanemab traditional approval in July 2023, and donanemab followed in 2024. Both require confirmed amyloid on a PET scan or spinal fluid test, regular infusions, and MRI monitoring for brain swelling or bleeding known as ARIA.
In its 18-month pivotal trial, lecanemab slowed decline on the main clinical scale by 27 percent compared with placebo. That is a slower slide, not a recovery, and eligibility is limited to mild cognitive impairment or mild dementia due to Alzheimer's.
Cholinesterase inhibitors are cheaper and widely prescribed, with side effects that include nausea and a slowed heart rate. The decision rule: if your parent has not had a formal diagnosis, none of these drugs are on the table yet. That is one more reason the doctor visit comes first.
Can memory loss actually be reversed?
Sometimes, but only when the cause is reversible. Memory loss from hypothyroidism, B12 deficiency, depression, sleep apnea, or sedating medications often improves with treatment. Alzheimer's disease has not been reversed in any trial, and approved drugs only slow decline. Headline devices like NeuroEM rest on an eight-person pilot without a control group, so be skeptical of any product promising reversal.
The NeuroEM study that generated the headlines was a 2019 open-label pilot. Eight people with mild to moderate Alzheimer's wore a transcranial electromagnetic treatment device for two months and showed improved test scores. There was no placebo group, and the device remains investigational, not FDA-approved.
Blood tests that measure tau proteins are improving early detection, and brain imaging can now confirm amyloid before symptoms are severe. Those are detection tools. They change when treatment starts, not whether the disease reverses.
What does improve within a stage is engagement, mood, attention, and daily function. That is the realistic target for any program, including ours, and it is the outcome families should measure.
What conditions mimic Alzheimer's and could be treatable?
The most common mimics are hypothyroidism, vitamin B12 deficiency, depression, obstructive sleep apnea, and untreated hearing loss. Others include side effects from anticholinergic drugs or sleep aids, urinary tract infections causing delirium, and normal pressure hydrocephalus. Each has a standard test or screen, and each can improve with treatment, which is why a workup precedes any program or supplement.
The National Institute on Aging notes that memory problems do not always mean dementia. Medications, emotional problems, and medical conditions can all cause lapses that look like Alzheimer's.
Bring a complete medication list to the appointment, including over-the-counter sleep aids and allergy pills. Diphenhydramine, found in many PM products, is an anticholinergic that can cloud thinking in older adults.
Ask about snoring and daytime sleepiness, which point to sleep apnea. Ask for a depression screen, because depression in older adults often shows up as forgetfulness rather than sadness. And get a hearing test, since the Lancet Commission ranked hearing loss as the largest single modifiable risk factor.
What is the difference between Alzheimer's disease and dementia?
Dementia is an umbrella term for a decline in memory, reasoning, or language severe enough to interfere with daily life. Alzheimer's disease is one cause of dementia, and the most common one, accounting for an estimated 60 to 80 percent of cases. Vascular dementia, Lewy body dementia, and frontotemporal dementia are other causes with different patterns.
The Alzheimer's Association explains the difference between dementia and Alzheimer's in plain terms: dementia describes the symptoms, Alzheimer's names a specific disease behind them.
There are two stages before dementia worth knowing. Normal aging means occasionally misplacing keys and remembering later. Mild cognitive impairment means measurable decline on testing while daily life still runs, and it does not always progress to dementia.
These labels matter for choosing support. CST evidence applies to mild and moderate dementia. Velma is designed for early memory loss and early Alzheimer's, when a parent can still follow a phone conversation and act on a routine prompt.
When should your parent see a doctor, and what tests are used?
See a doctor as soon as memory lapses repeat, affect safety, or worry the family, rather than waiting for a crisis. Medicare covers a cognitive assessment at the annual wellness visit and a separate care planning visit after a diagnosis. Expect a history, a screening test such as the MoCA or MMSE, blood work, and often brain imaging.
Triggers that justify a visit now include missed medications and getting lost on a familiar route. Repeating the same question within minutes or unpaid bills piling up also count. One episode is a flag; a pattern is a reason to book.
Medicare's cognitive assessment and care plan services page describes what is covered. Blood work usually includes thyroid function, B12, a complete blood count, and a metabolic panel. An MRI or CT scan rules out strokes, tumors, and fluid buildup.
A specialist may add amyloid PET imaging, spinal fluid analysis, or newer blood biomarker tests. Our guide to what insurance covers for cognitive support programs explains which of these steps Medicare pays for and which it does not.
How should you evaluate any memory product or alternative claim?
Run five checks, starting with the trial rather than the testimonial. Confirm the study population matches your parent's stage, and look for FTC or FDA warning letters. Ask a pharmacist about drug interactions, and price it against the alternatives with evidence. A product that passes none of these belongs in the unproven tier regardless of how it is advertised.
Red flags include the phrase clinically proven with no citation, a patented proprietary blend, and the word reverses. Countdown timers and testimonials from people whose diagnosis is never stated are two more. A legitimate product names its study, its sample size, and its limits.
Apply the same test to us. Velma's published results are individual stories, not a randomized trial. Our sessions use evidence-based cognitive exercises, and our pricing is public at $199 a month. The first session is free so you can judge the fit yourself.
On cost, the comparison is simple. Velma costs $199 a month, which is a fraction of what full-time adult day care costs at the national median. We compared the app route separately in Velma vs brain games at home.
How did we compare these options?
We compared published pricing for Velma, Medicare coverage rules for cognitive rehabilitation therapy, and the national cost survey figure for adult day care. We also reviewed provider listings for group CST and BrainHQ's public subscription model. We checked each option's evidence against the Cochrane CST review, the Lancet Commission report, and FDA and FTC records.
How do you get started with Velma?
Start with the free first session, which comes with no commitment and no insurance authorization. You tell us about your parent, and we schedule a short phone session at a time that suits them. A care manager follows up with what we observed. If it fits, the program continues at $199 a month with daily sessions and family alerts.
You can book your parent's free first session at heyvelma.com. Reach our team through heyvelma.com with questions before you decide.
Velma is not a substitute for a physician-directed treatment plan. If your parent has not had a cognitive workup yet, book that appointment first and start Velma alongside it.
What do people also ask?
What is the best medication to help with memory loss?
There is no single best drug. Cholinesterase inhibitors such as donepezil, rivastigmine, and galantamine treat Alzheimer's symptoms, and memantine helps in moderate to severe stages. The anti-amyloid infusions lecanemab and donanemab slow early Alzheimer's modestly in people with confirmed amyloid. All require a physician's diagnosis, and none are available over the counter.
What mimics Alzheimer's?
Hypothyroidism, vitamin B12 deficiency, depression, obstructive sleep apnea, and untreated hearing loss can all look like Alzheimer's. So can side effects from anticholinergic drugs and sleep aids, urinary tract infections causing delirium, and normal pressure hydrocephalus. Each has a standard test, and each can improve with treatment, so ask for a full workup before assuming dementia.
Is there anything better than Prevagen for memory?
Yes, and the FTC and New York Attorney General charged Prevagen's marketers with deceptive memory claims in 2017. The company's own study failed on its primary measures. Cognitive stimulation therapy, aerobic exercise, hearing correction, and blood pressure control all have stronger evidence. Velma delivers daily structured cognitive sessions at home for $199 a month.
What is the main difference between Alzheimer's disease and dementia?
Dementia is the umbrella term for a decline in memory, reasoning, or language that interferes with daily life. Alzheimer's disease is the most common cause of dementia, estimated at 60 to 80 percent of cases. Vascular, Lewy body, and frontotemporal dementia are other causes with different symptom patterns and treatment paths.
Is Heyvlema the same as Hey Velma?
We cannot find any product, supplement, or company called Heyvlema, a spelling one letter off from Hey Velma. Velma is our daily phone-based program, not a pill. It pairs AI assistants with a dedicated care manager for cognitive sessions, routine support, and family alerts. It costs $199 a month, and the first session is free.
Suggested Article: